|
US20110123440A1
(en)
*
|
2005-03-29 |
2011-05-26 |
Genevieve Hansen |
Altered Antibody FC Regions and Uses Thereof
|
|
KR101030978B1
(ko)
*
|
2008-07-10 |
2011-04-28 |
(주) 에이프로젠 |
동물세포용 재조합 발현벡터
|
|
CN101747440B
(zh)
*
|
2008-12-18 |
2014-05-07 |
嘉和生物药业有限公司 |
一种TNFR-Fc融合蛋白及其用途
|
|
US20110117092A1
(en)
*
|
2009-10-20 |
2011-05-19 |
The Regents Of The University Of Michigan |
Compositions and methods for inhibiting g-csfr
|
|
SG10201503351RA
(en)
|
2010-01-19 |
2015-06-29 |
Harvard College |
Engineered Opsonin for Pathogen Detection and Treatment
|
|
CN102260343A
(zh)
*
|
2010-05-25 |
2011-11-30 |
健能隆医药技术（上海）有限公司 |
重组人g-csf二聚体在治疗神经损伤疾病中的用途
|
|
US20130164288A1
(en)
*
|
2010-09-07 |
2013-06-27 |
Protalix Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
|
KR101333958B1
(ko)
|
2010-10-20 |
2013-11-27 |
주식회사 한독 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
JP6077461B2
(ja)
|
2011-01-04 |
2017-02-08 |
ウニヴェルズィテート チューリッヒ |
アルツハイマー病の予防又は治療のためのｉｌ−１２及び／又はｉｌ−２３のモジュレーター
|
|
CN102585013B
(zh)
*
|
2011-01-07 |
2014-04-23 |
中国人民解放军军事医学科学院生物工程研究所 |
一种含有ω干扰素的融合蛋白及制备方法
|
|
AU2012222366A1
(en)
|
2011-03-02 |
2013-08-01 |
Novo Nordisk A/S |
Coagulation factor-targeting to TLT-1 on activated platelets
|
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
|
RU2639526C2
(ru)
*
|
2011-06-28 |
2017-12-21 |
ИНХИБРКС ЭлЭлСи |
Слитые полипептиды, содержащие домен wap, и способы их применения
|
|
SMT201900520T1
(it)
*
|
2011-06-28 |
2019-11-13 |
Inhibrx Lp |
Polipeptidi di fusione serpinici e relativi metodi d'uso
|
|
US8951966B2
(en)
*
|
2011-07-01 |
2015-02-10 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides, and uses and methods thereof for treatment of metabolic disorders and diseases
|
|
CA3149018A1
(en)
|
2011-07-18 |
2013-01-24 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
|
EP2737905B1
(en)
*
|
2011-07-25 |
2019-09-11 |
Generon (Shanghai) Corporation Ltd. |
Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases
|
|
KR20130049671A
(ko)
|
2011-11-04 |
2013-05-14 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
US12384848B2
(en)
|
2011-12-19 |
2025-08-12 |
The Rockefeller University |
Anti-inflammatory polypeptides
|
|
EA201892339A3
(ru)
*
|
2011-12-19 |
2019-06-28 |
Дзе Рокфеллер Юниверсити |
Несиалированный выделенный полипептид, способ получения указанного полипептида и фармацевтическая композиция для лечения воспалительного заболевания
|
|
KR101183615B1
(ko)
*
|
2011-12-28 |
2012-09-17 |
재단법인 경기과학기술진흥원 |
Ｗｎｔ에 결합하는 신규한 재조합 단백질
|
|
AR090281A1
(es)
|
2012-03-08 |
2014-10-29 |
Hanmi Science Co Ltd |
Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
|
|
US9603897B2
(en)
|
2012-03-12 |
2017-03-28 |
Massachusetts Institute Of Technology |
Methods for treating tissue damage associated with ischemia with apolipoprotein D
|
|
JP5855239B2
(ja)
*
|
2012-04-23 |
2016-02-09 |
株式会社Ｎｒｌファーマ |
ラクトフェリン融合タンパク質及びその製造方法
|
|
CN104870019A
(zh)
|
2012-11-27 |
2015-08-26 |
阿特根公司 |
用于稳定蛋白质和Fc结构域融合的融合蛋白的组合物
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
EP2956003A2
(en)
|
2013-02-13 |
2015-12-23 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Proteins with modified glycosylation and methods of production thereof
|
|
KR20160002713A
(ko)
|
2013-02-13 |
2016-01-08 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
|
|
JP2016511275A
(ja)
*
|
2013-03-11 |
2016-04-14 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
成長ホルモン化合物
|
|
EA201591700A1
(ru)
*
|
2013-03-14 |
2015-12-30 |
Ридженерон Фармасьютикалз, Инк. |
Гибридные белки апелина и их применение
|
|
CN114717206A
(zh)
|
2013-03-15 |
2022-07-08 |
Atyr 医药公司 |
组氨酰-trna合成酶-fc缀合物
|
|
US10551379B2
(en)
|
2013-03-15 |
2020-02-04 |
President And Fellows Of Harvard College |
Methods and compositions for improving detection and/or capture of a target entity
|
|
RS61400B1
(sr)
|
2013-05-02 |
2021-02-26 |
Anaptysbio Inc |
Antitela usmerena protiv programirane smrti-1 (pd-1)
|
|
EP3848045A1
(en)
|
2013-05-21 |
2021-07-14 |
President and Fellows of Harvard College |
Engineered heme-binding compositions and uses thereof
|
|
KR101895634B1
(ko)
*
|
2013-05-31 |
2018-09-05 |
한미약품 주식회사 |
변이된 힌지 영역을 포함하는 IgG4 Fc 단편
|
|
AR096890A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
|
|
CN104231086B
(zh)
*
|
2013-08-27 |
2019-12-13 |
北京韩美药品有限公司 |
双功能融合蛋白及其制备方法和用途
|
|
US20150093399A1
(en)
|
2013-08-28 |
2015-04-02 |
Bioasis Technologies, Inc. |
Cns-targeted conjugates having modified fc regions and methods of use thereof
|
|
CA2931299C
(en)
|
2013-11-20 |
2024-03-05 |
Regeneron Pharmaceuticals, Inc. |
Aplnr modulators and uses thereof
|
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
|
TWI754319B
(zh)
|
2014-03-19 |
2022-02-01 |
美商再生元醫藥公司 |
用於腫瘤治療之方法及抗體組成物
|
|
KR102385120B1
(ko)
*
|
2014-03-31 |
2022-04-12 |
한미약품 주식회사 |
면역글로불린 Fc 단편 결합을 이용한 단백질 및 펩타이드의 용해도를 개선시키는 방법
|
|
KR20150135148A
(ko)
*
|
2014-05-23 |
2015-12-02 |
주식회사 제넥신 |
Pd-l1 융합 단백질 및 이의 용도
|
|
EP3149030A2
(en)
|
2014-06-02 |
2017-04-05 |
Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme |
Production of fc fragments
|
|
US10441595B2
(en)
*
|
2014-06-26 |
2019-10-15 |
Brigham Young University |
Methods for treating fungal infections
|
|
KR102272213B1
(ko)
*
|
2014-07-08 |
2021-07-01 |
삼성전자주식회사 |
표적화 부위, 절단 부위, 및 세포막 투과 부위를 포함하는 융합 단백질 및 그의 용도
|
|
TW201629100A
(zh)
*
|
2014-10-06 |
2016-08-16 |
格納西尼有限公司 |
人類ＩｇＧ４ Ｆｃ多肽變異體
|
|
ES2809455T3
(es)
|
2014-11-17 |
2021-03-04 |
Regeneron Pharma |
Métodos para tratamiento tumoral usando anticuerpo biespecífico CD3xCD20
|
|
ES2826566T3
(es)
|
2014-11-21 |
2021-05-18 |
Bristol Myers Squibb Co |
Anticuerpos que comprenden regiones constantes pesadas modificadas
|
|
JP6805142B2
(ja)
|
2014-11-21 |
2020-12-23 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｃｄ７３に対する抗体およびその使用
|
|
AR103268A1
(es)
|
2014-12-23 |
2017-04-26 |
Bristol Myers Squibb Co |
Anticuerpos contra tigit
|
|
KR101825048B1
(ko)
*
|
2014-12-31 |
2018-02-05 |
주식회사 제넥신 |
GLP 및 면역글로불린 하이브리드 Fc 융합 폴리펩타이드 및 이의 용도
|
|
CN105801705B
(zh)
*
|
2014-12-31 |
2019-05-24 |
天境生物科技(上海)有限公司 |
含胰高血糖素样肽-1和免疫球蛋白杂合Fc的融合多肽及其用途
|
|
TWI626946B
(zh)
|
2015-01-09 |
2018-06-21 |
格納西尼有限公司 |
使用持續釋放ｅｐｏ之製劑治療貧血之方法
|
|
EA202191471A1
(ru)
|
2015-03-04 |
2022-01-31 |
Зе Рокфеллер Юниверсити |
Противовоспалительные полипептиды
|
|
DK3277725T3
(da)
|
2015-03-30 |
2021-01-11 |
Regeneron Pharma |
Konstante tungkædeområder med reduceret binding til FC-gammareceptorer
|
|
EP3288965B1
(en)
*
|
2015-04-29 |
2019-06-26 |
Mediolanum Farmaceutici S.p.A. |
A soluble chimeric interleukin-10 receptor and therapeutic use thereof
|
|
WO2016178087A1
(en)
|
2015-05-04 |
2016-11-10 |
Biosourcing Sa |
Transgenic production of chorionic gonadotropin
|
|
CN107979973A
(zh)
|
2015-05-04 |
2018-05-01 |
法国化学与生物科技实验室 |
Fc融合蛋白质的转基因生产
|
|
AR105616A1
(es)
*
|
2015-05-07 |
2017-10-25 |
Lilly Co Eli |
Proteínas de fusión
|
|
AU2016271111B2
(en)
|
2015-05-29 |
2022-04-28 |
Bristol-Myers Squibb Company |
Antibodies against OX40 and uses thereof
|
|
EP3303380B1
(en)
|
2015-06-02 |
2020-01-15 |
Novo Nordisk A/S |
Insulins with polar recombinant extensions
|
|
HK1256149A1
(zh)
|
2015-06-11 |
2019-09-13 |
格纳西尼有限公司 |
经修饰的白细胞介素-7蛋白及其用途
|
|
MX2017016502A
(es)
|
2015-06-29 |
2018-03-12 |
Univ Rockefeller |
Anticuerpos contra cd40 con actividad agonista mejorada.
|
|
FR3038517B1
(fr)
|
2015-07-06 |
2020-02-28 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Utilisation de fragments fc modifies en immunotherapie
|
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
|
MY195059A
(en)
|
2015-09-23 |
2023-01-05 |
Regeneron Pharma |
Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof
|
|
WO2017055582A1
(en)
|
2015-10-01 |
2017-04-06 |
Novo Nordisk A/S |
Protein conjugates
|
|
KR102147997B1
(ko)
*
|
2015-10-23 |
2020-08-25 |
주식회사 제넥신 |
피부 주름 개선용 조성물
|
|
KR101773858B1
(ko)
|
2015-10-23 |
2017-09-01 |
명지대학교 산학협력단 |
피부 주름 개선용 조성물
|
|
KR102668200B1
(ko)
*
|
2015-10-28 |
2024-05-23 |
주식회사유한양행 |
지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물
|
|
KR102386735B1
(ko)
*
|
2015-11-06 |
2022-04-14 |
주식회사 제넥신 |
변형된 인터루킨-7 융합 단백질의 제형
|
|
US11708399B2
(en)
|
2015-12-04 |
2023-07-25 |
Genexine, Inc. |
Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases
|
|
US11357827B2
(en)
*
|
2015-12-04 |
2022-06-14 |
Genexine, Inc. |
Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein
|
|
AR107483A1
(es)
|
2016-01-29 |
2018-05-02 |
Hanmi Pharm Ind Co Ltd |
Conjugado de enzimas terapéuticas
|
|
WO2017142331A1
(en)
|
2016-02-17 |
2017-08-24 |
Genexine, Inc. |
Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
|
|
EP3416677B1
(en)
|
2016-02-17 |
2022-08-03 |
Genexine, Inc. |
Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
|
|
AU2017228470A1
(en)
|
2016-03-04 |
2018-08-30 |
Bristol-Myers Squibb Company |
Combination therapy with anti-CD73 antibodies
|
|
CN116063494A
(zh)
|
2016-03-04 |
2023-05-05 |
洛克菲勒大学 |
具有增强的激动剂活性的cd40的抗体
|
|
KR102682118B1
(ko)
*
|
2016-04-29 |
2024-07-08 |
주식회사유한양행 |
Ccl3 변이체를 포함하는 융합 단백질 및 이의 용도
|
|
KR102543118B1
(ko)
|
2016-05-27 |
2023-06-14 |
아게누스 인코포레이티드 |
항-tim-3 항체 및 이의 사용 방법
|
|
CN106191072A
(zh)
*
|
2016-08-04 |
2016-12-07 |
沈沭彤 |
重组人源嵌合GcFc基因片段及融合蛋白
|
|
CN118105512A
(zh)
*
|
2016-08-30 |
2024-05-31 |
株式会社吉耐森 |
含有hGH融合蛋白的治疗生长激素缺乏症的药物组合物
|
|
WO2018053234A1
(en)
|
2016-09-15 |
2018-03-22 |
Acceleron Pharma, Inc. |
Twisted gastrulation polypeptides and uses thereof
|
|
US10906957B2
(en)
|
2016-09-27 |
2021-02-02 |
Epicentrx, Inc. |
Immunomodulatory fusion proteins
|
|
EP3533870A4
(en)
|
2016-10-28 |
2020-04-08 |
NRL Pharma, Inc. |
LACTOFERRIN / ALBUMIN FUSION PROTEIN AND PROCESS FOR PRODUCING THE SAME
|
|
CN110049777A
(zh)
|
2016-11-01 |
2019-07-23 |
安奈普泰斯生物有限公司 |
针对程序性死亡-1(pd-1)的抗体
|
|
US11912750B2
(en)
*
|
2016-11-10 |
2024-02-27 |
Keros Therapeutics, Inc. |
GDNF fusion polypeptides and methods of use thereof
|
|
CN108264562B
(zh)
*
|
2016-12-30 |
2021-08-10 |
惠和生物技术(上海)有限公司 |
一种结合cd3和t细胞正共刺激分子的双功能分子及其应用
|
|
PT3565844T
(pt)
|
2017-01-09 |
2023-05-02 |
Tesaro Inc |
Métodos de tratamento de cancro com anticorpos anti-pd-1
|
|
CN106832002A
(zh)
*
|
2017-02-16 |
2017-06-13 |
上海科医联创生物科技有限公司 |
一种靶向pd‑1的融合蛋白及其相关应用
|
|
KR102625293B1
(ko)
|
2017-03-06 |
2024-01-15 |
알토 바이오사이언스 엘엘씨 |
Il-12 및 il-18로의 il-15-기반 융합
|
|
CN108623692B
(zh)
*
|
2017-03-20 |
2020-11-17 |
徐寒梅 |
一种融合蛋白及其制备方法和其应用
|
|
JP2020513019A
(ja)
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|
|
TWI788340B
(zh)
|
2017-04-07 |
2023-01-01 |
美商必治妥美雅史谷比公司 |
抗icos促效劑抗體及其用途
|
|
ES2994451T3
(en)
|
2017-04-20 |
2025-01-24 |
Atyr Pharma Inc |
Compositions for treating lung inflammation
|
|
CN110709520B
(zh)
|
2017-04-21 |
2024-04-05 |
株式会社柳韩洋行 |
用于产生双功能蛋白质及其衍生物的方法
|
|
MX2019013132A
(es)
|
2017-05-25 |
2020-01-27 |
Bristol Myers Squibb Co |
Anticuerpos que comprenden regiones constantes pesadas modificadas.
|
|
CN107082815A
(zh)
*
|
2017-06-28 |
2017-08-22 |
杭州皓阳生物技术有限公司 |
一种fsh‑hsa融合蛋白及其制备方法
|
|
CN111566214B
(zh)
*
|
2017-07-06 |
2024-03-08 |
日东纺绩株式会社 |
抗人IgG4单克隆抗体及利用该抗体的人IgG4测定试剂
|
|
US11883503B2
(en)
|
2017-09-25 |
2024-01-30 |
Dingfu Biotarget Co., Ltd. |
Methods and compositions for cancer treatment
|
|
KR102757384B1
(ko)
|
2017-09-27 |
2025-01-20 |
에피센트알엑스, 인코포레이티드 |
면역조절 융합 단백질
|
|
EP3708661A4
(en)
|
2017-12-22 |
2021-12-01 |
Hanmi Pharm. Co., Ltd. |
THERAPEUTIC ENZYMFUSION PROTEIN WITH A NEW STRUCTURE AND ITS USE
|
|
CN111788227B
(zh)
|
2017-12-27 |
2025-02-25 |
百时美施贵宝公司 |
抗cd40抗体及其用途
|
|
TW201930343A
(zh)
*
|
2018-01-08 |
2019-08-01 |
南韓商普羅根有限公司 |
包含IgE受體之重組型胞外區域的藥學組成物
|
|
MY209615A
(en)
*
|
2018-01-08 |
2025-07-24 |
Gi Innovation Inc |
Extracellular domain of alpha subunit of ige fc receptor, pharmaceutical composition comprising same and method for producing same
|
|
PE20210108A1
(es)
*
|
2018-01-12 |
2021-01-19 |
Gi Innovation Inc |
Composicion que comprende probioticos y polipeptido que tiene afinidad de union para ige y uso de la misma
|
|
CN110054700A
(zh)
*
|
2018-01-18 |
2019-07-26 |
分子克隆研究室有限公司 |
长效治疗性融合蛋白
|
|
WO2019195770A1
(en)
|
2018-04-06 |
2019-10-10 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-nrp2 antibodies
|
|
KR102194644B1
(ko)
|
2018-04-26 |
2020-12-24 |
주식회사 굳티셀 |
신규한 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물
|
|
US12246059B2
(en)
|
2018-05-04 |
2025-03-11 |
Ilkogen Ilaç Sanayi Ve Ticaret A.S. |
Stable hybrid FC fusion G-CSF formulation
|
|
AU2019309472A1
(en)
|
2018-07-24 |
2021-03-18 |
Good T Cells, Inc. |
Composition for preventing or treating immune-related diseases
|
|
KR102676582B1
(ko)
|
2018-07-25 |
2024-06-20 |
주식회사유한양행 |
갑상선 자극 호르몬 수용기(thyrotropin receptor, TSHR) 단편을 포함하는 융합 단백질 및 이의 용도
|
|
AU2019312366B2
(en)
|
2018-07-26 |
2025-08-14 |
Atyr Pharma, Inc. |
Compositions and methods for treating NRP2-associated diseases
|
|
ES3009025T3
(en)
|
2018-08-31 |
2025-03-25 |
Regeneron Pharma |
Dosing strategy that mitigates cytokine release syndrome for cd3/cd20 bispecific antibodies
|
|
EP3848388B1
(en)
*
|
2018-09-05 |
2025-08-20 |
LG Chem, Ltd. |
Fusion polypeptide comprising polypeptide region that can be o-glycosylated
|
|
WO2020053661A1
(en)
|
2018-09-13 |
2020-03-19 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Methods of purifying antibodies from the milk of transgenic non-human mammals comprising the use of chitosan
|
|
CA3119341A1
(en)
|
2018-11-16 |
2020-05-22 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor
|
|
JP2022513653A
(ja)
|
2018-11-28 |
2022-02-09 |
ブリストル－マイヤーズ スクイブ カンパニー |
修飾された重鎖定常領域を含む抗体
|
|
US11813310B2
(en)
|
2019-02-13 |
2023-11-14 |
Ilkogen Ilaç Sanayi Ve Ticaret A.S. |
Long-acting G-CSF for preventing neutropenia or reducing duration of neutropenia
|
|
EP3930687A4
(en)
|
2019-02-25 |
2023-06-07 |
The University of Chicago |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
|
|
CN119950685A
(zh)
*
|
2019-03-08 |
2025-05-09 |
格纳西尼有限公司 |
Glp-1融合蛋白及其用途
|
|
EP3995508A4
(en)
*
|
2019-05-14 |
2023-09-27 |
Progen Co., Ltd. |
NOVEL MODIFIED IMMUNOGLOBULIN-FC FUSION PROTEIN AND USE THEREOF
|
|
DK3744319T3
(da)
*
|
2019-05-28 |
2023-01-16 |
Ilkogen Ilac Sanayi Ve Ticaret A S |
Stabil lyofiliseret formulering til hybrid fc-fusioneret g-csf
|
|
KR20210006300A
(ko)
*
|
2019-07-08 |
2021-01-18 |
주식회사 프로젠 |
신규 알러지 질환 치료용 약학적 조성물
|
|
MX2022000285A
(es)
|
2019-07-08 |
2022-02-03 |
Gi Innovation Inc |
Dimero de polipeptido con alto contenido de acido sialico, que comprende el dominio extracelular de la subunidad alfa del receptor fc de ige y composicion farmaceutica que comprende el mismo.
|
|
CN114302891A
(zh)
|
2019-07-08 |
2022-04-08 |
普罗根有限公司 |
新的il-10变体蛋白及其用途
|
|
WO2021006375A1
(ko)
*
|
2019-07-08 |
2021-01-14 |
(주)지아이이노베이션 |
Ige fc 수용체의 알파 서브유닛의 세포외 도메인을 포함하는 시알산 함량이 높은 폴리펩티드 이량체 및 이를 포함하는 약학적 조성물
|
|
CN114341197A
(zh)
|
2019-07-08 |
2022-04-12 |
普罗根有限公司 |
新的融合蛋白及其用途
|
|
CA3143636A1
(en)
|
2019-07-12 |
2021-01-21 |
Michael Lim |
Compositions and methods for treating cerebral vasospasm
|
|
AU2020358854B2
(en)
|
2019-10-03 |
2026-08-13 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-NRP2 antibodies
|
|
KR102899743B1
(ko)
*
|
2019-12-11 |
2025-12-12 |
주식회사 엘지화학 |
O-글리코실화 가능한 폴리펩타이드 영역 및 gdf15를 포함하는 융합 폴리펩타이드
|
|
CN111057154B
(zh)
*
|
2019-12-23 |
2023-06-06 |
南京融捷康生物科技有限公司 |
基于驼源Fc片段的免疫原的制备及应用
|
|
AU2021207586A1
(en)
|
2020-01-13 |
2022-07-21 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of IL-7 protein and a bispecific antibody
|
|
US20230123454A1
(en)
*
|
2020-01-23 |
2023-04-20 |
Genexine, Inc. |
Fusion protein comprising pd-l1 protein and use thereof
|
|
AU2021217373A1
(en)
|
2020-02-05 |
2022-08-04 |
Neoimmunetech, Inc. |
Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells
|
|
CN115485292A
(zh)
|
2020-03-12 |
2022-12-16 |
鄂斯尔美塔根公司 |
新的双特异性蛋白及其用途
|
|
LT3972987T
(lt)
*
|
2020-04-10 |
2023-09-25 |
Akston Biosciences Corporation |
Antigenui specifinė imunoterapija, skirta sulietiems covid-19 baltymams ir naudojimo būdai
|
|
WO2021230705A1
(ko)
*
|
2020-05-14 |
2021-11-18 |
주식회사 프로젠 |
신규 재조합 융합단백질 및 그의 용도
|
|
US20230192867A1
(en)
|
2020-05-15 |
2023-06-22 |
Bristol-Myers Squibb Company |
Antibodies to garp
|
|
WO2022000136A1
(en)
*
|
2020-06-28 |
2022-01-06 |
Dingfu Biotarget Co., Ltd. |
Methods and compositions for cancer treatment
|
|
CN111944058B
(zh)
*
|
2020-07-28 |
2021-12-17 |
中国农业大学 |
一种兼具抗菌、抗炎、中和内毒素和免疫调节活性的多功能杂合肽及其制备方法和应用
|
|
KR102450007B1
(ko)
*
|
2020-10-16 |
2022-10-04 |
주식회사 아이엠바이오로직스 |
IgM 영역을 이용한 융합단백질 플랫폼
|
|
WO2022093718A1
(en)
|
2020-10-26 |
2022-05-05 |
Neoimmunetech, Inc. |
Methods of inducing stem cell mobilization
|
|
KR20230104176A
(ko)
|
2020-11-02 |
2023-07-07 |
네오이뮨텍, 인코퍼레이티드 |
코로나바이러스의 치료를 위한 인터류킨-7의 용도
|
|
JP2023549112A
(ja)
|
2020-11-05 |
2023-11-22 |
ネオイミューンテック， インコーポレイテッド |
Ｉｌ－７タンパク質とヌクレオチドワクチンの組み合わせで腫瘍を治療する方法
|
|
EP4265269A1
(en)
|
2020-12-16 |
2023-10-25 |
Good T Cells, Inc. |
Use of taci protein
|
|
CN114671956B
(zh)
*
|
2020-12-24 |
2026-06-30 |
鲁南制药集团股份有限公司 |
一种重组白细胞抑制因子和水蛭肽嵌合蛋白突变体
|
|
EP4674865A3
(en)
|
2021-03-09 |
2026-03-25 |
GI Innovation, Inc. |
Formulation of fusion protein including extracellular domain of alpha subunit of ige fc receptor
|
|
CN113603791A
(zh)
*
|
2021-08-11 |
2021-11-05 |
厦门目青股权投资合伙企业(有限合伙) |
一种融合蛋白及其应用
|
|
MX2024006318A
(es)
|
2021-11-26 |
2024-08-14 |
Genexine Inc |
Formulacion para administracion de alta concentracion de proteina de fusion de hormona del crecimiento.
|
|
CN119836296A
(zh)
|
2021-12-30 |
2025-04-15 |
新免疫技术有限公司 |
用il-7蛋白和vegf拮抗剂的组合治疗肿瘤的方法
|
|
KR20240163103A
(ko)
|
2022-03-10 |
2024-11-18 |
주식회사 제넥신 |
두경부암 치료를 위한 삼중 복합약물 투여요법
|
|
WO2023173084A1
(en)
|
2022-03-11 |
2023-09-14 |
University Of Rochester |
Cyclopeptibodies and uses thereof
|
|
JP2026504619A
(ja)
|
2022-11-07 |
2026-02-06 |
ネオイミューンテック， インコーポレイテッド |
非メチル化ｍｇｍｔプロモーターを含む腫瘍を治療する方法
|
|
CN115850517B
(zh)
*
|
2022-11-14 |
2024-10-11 |
沈阳药科大学 |
一种提高GLP-1 Fc融合蛋白产量的方法
|
|
JP2026508960A
(ja)
|
2023-03-17 |
2026-03-13 |
クロジェン・テクノロジー・カンパニー・リミテッド |
自己免疫疾患治療用新規融合タンパク質
|
|
AU2024313859A1
(en)
|
2023-06-22 |
2026-01-15 |
Slbigen Inc. |
Novel bispecific fusion protein and use thereof
|
|
KR20260033048A
(ko)
*
|
2023-07-03 |
2026-03-10 |
네오이뮨텍, 인코퍼레이티드 |
이종이합체 fc 분자 및 이의 용도
|
|
KR102943929B1
(ko)
|
2024-08-21 |
2026-03-26 |
이화여자대학교 산학협력단 |
추락사고로 인한 인명피해방지를 위한 안전 장비 및 안전 장비의 에어백 작동 제어 방법
|
|
WO2026122407A1
(en)
|
2024-12-04 |
2026-06-11 |
Merck Sharp & Dohme Llc |
Amyloid beta binder, and uses thereof
|